AYTU · AYTU BIOPHARMA INC

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 17 years of age; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 15 years of age. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.

7900 East Union Avenue, Denver, CO, 80237, United States
Drug Manufacturers - Specialty & Generic
Healthcare

Market Cap

28.91M

52 Wk Range

$1.75 - $3.07

Previous Close

$2.66

Open

$2.66

Volume

634,764

Day Range

$2.65 - $2.66

Enterprise Value

19.92M

Cash

25.49M

Avg Qtr Burn

-275K

Insider Ownership

8.26%

Institutional Own.

34.39%

Qtr Updated

Sep 30th 2026